Disclosure Of Fair Value Measurement [Text Block]

PureTech Health plc - Filing #2024169

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
693,973,000 USD
702,647,000 USD
Reconciliation of changes in fair value measurement, assets [abstract]
Changes in fair value measurement, assets [abstract]
Gains (losses) recognised in profit or loss, fair value measurement, assets [abstract]
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, assets
77,945,000 USD
20,456,000 USD
32,060,000 USD
18,848,000 USD
179,316,000 USD
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
235,741,000 USD
155,057,000 USD
Reconciliation of changes in fair value measurement, liabilities [abstract]
Changes in fair value measurement, liabilities [abstract]
Gains (losses) recognised in profit or loss, fair value measurement, liabilities [abstract]
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities
2,650,000 USD
137,063,000 USD
9,606,000 USD
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
458,232,000 USD
83,820,000 USD
9,538,000 USD
5,835,000 USD
290,262,000 USD
5,461,000 USD
182,000 USD
55,115,000 USD
44,626,000 USD
138,506,000 USD
464,066,000 USD
547,589,000 USD
8,882,000 USD
14,478,000 USD
5,369,000 USD
289,624,000 USD
149,516,000 USD
26,492,000 USD
5,455,000 USD
89,000 USD
138,506,000 USD
542,220,000 USD
USD
199,871,000 USD
40,077,000 USD
584,147,000 USD
138,506,000 USD
593,515,000 USD
289,303,000 USD
9,368,000 USD
469,000 USD
5,444,000 USD
260,429,000 USD
16,209,000 USD
669,748,000 USD
5,417,000 USD
138,506,000 USD
24,050,000 USD
288,978,000 USD
469,000 USD
USD
653,539,000 USD
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.